Status:
RECRUITING
A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment
Lead Sponsor:
VA Office of Research and Development
Conditions:
Dependence, Opioid
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The US Veteran community continues to feel the impact of the overdose crisis, and opioid use disorder (OUD) diagnoses among Veterans continue to rise. Medication treatment (e.g., buprenorphine, methad...
Detailed Description
The current project will develop and pilot a brief, manualized intervention for improving Veterans' interpersonal functioning, community reintegration, and quality of life during early medication trea...
Eligibility Criteria
Inclusion
- Meets current Diagnostic and Statistical Manual - 5th Edition criteria for moderate to severe opioid use disorder
- Within 12 weeks of initiating buprenorphine, methadone, or naltrexone treatment for opioid use disorder following at least 2 months without treatment
- Competent to provide written informed consent
Exclusion
- Evidence of active psychosis or mania
- Suicidality requiring inpatient hospitalization
- Active substance use requiring detoxification
- Cognitive impairment that would interfere with study participation
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05189223
Start Date
September 1 2023
End Date
March 31 2027
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Bedford HealthCare System, Bedford, MA
Bedford, Massachusetts, United States, 01730-1114